AU2781899A - Use of a cardiac purinoceptor to effect cellular glucose uptake - Google Patents
Use of a cardiac purinoceptor to effect cellular glucose uptakeInfo
- Publication number
- AU2781899A AU2781899A AU27818/99A AU2781899A AU2781899A AU 2781899 A AU2781899 A AU 2781899A AU 27818/99 A AU27818/99 A AU 27818/99A AU 2781899 A AU2781899 A AU 2781899A AU 2781899 A AU2781899 A AU 2781899A
- Authority
- AU
- Australia
- Prior art keywords
- purinoceptor
- cardiac
- glucose uptake
- cellular glucose
- effect cellular
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US7567898P | 1998-02-24 | 1998-02-24 | |
US60075678 | 1998-02-24 | ||
PCT/US1999/003881 WO1999043326A1 (en) | 1998-02-24 | 1999-02-23 | Use of a cardiac purinoceptor to effect cellular glucose uptake |
Publications (1)
Publication Number | Publication Date |
---|---|
AU2781899A true AU2781899A (en) | 1999-09-15 |
Family
ID=22127304
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU27818/99A Abandoned AU2781899A (en) | 1998-02-24 | 1999-02-23 | Use of a cardiac purinoceptor to effect cellular glucose uptake |
Country Status (2)
Country | Link |
---|---|
AU (1) | AU2781899A (en) |
WO (1) | WO1999043326A1 (en) |
Families Citing this family (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
MA26662A1 (en) * | 1998-07-21 | 2004-12-20 | Smithkline Beecham Plc | THIAZOLIDINEDIONE DERIVATIVES, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM AND THEIR USE |
IL140664A0 (en) * | 1998-07-21 | 2002-02-10 | Smithkline Beecham Plc | Use of glucose uptake enhancer for reducing apoptosis |
US6613785B2 (en) | 1998-07-21 | 2003-09-02 | Smithkline Beecham Plc | Use of glucose uptake enhancer for reducing post-ischemic injury of the heart |
US20050009777A1 (en) * | 2001-07-25 | 2005-01-13 | Mack Stephen Robert | Non-natural carbon-linked nucleotides and dinucleotides |
WO2003028712A2 (en) * | 2001-09-28 | 2003-04-10 | Universite Libre De Bruxelles | Purinergic and pyrimidinergic receptor agonists for the treatment of activated cd4+ t lymphocyte-mediated immune diseases |
WO2006052007A1 (en) * | 2004-11-11 | 2006-05-18 | Takeda Pharmaceutical Company Limited | Glycemic controlling agent |
EP2036567A3 (en) * | 2005-12-06 | 2009-12-09 | P2-Science APS | Modulation of the P2Y2 receptor pathway |
WO2014108449A1 (en) | 2013-01-08 | 2014-07-17 | Atrogi Ab | A screening method, a kit, a method of treatment and a compound for use in a method of treatment |
WO2014108531A1 (en) | 2013-01-13 | 2014-07-17 | Atrogi Ab | A screening method, a kit, a method of treatment and a compound for use in a method of treatment |
US9891212B2 (en) | 2013-12-16 | 2018-02-13 | Atrogi Ab | Screening method, a kit, a method of treatment and a compound for use in a method of treatment |
GB201714745D0 (en) | 2017-09-13 | 2017-10-25 | Atrogi Ab | New compounds and uses |
GB201714740D0 (en) | 2017-09-13 | 2017-10-25 | Atrogi Ab | New compounds and uses |
GB201714734D0 (en) | 2017-09-13 | 2017-10-25 | Atrogi Ab | New compounds and uses |
GB201714736D0 (en) | 2017-09-13 | 2017-10-25 | Atrogi Ab | New compounds and uses |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5712258A (en) * | 1995-03-23 | 1998-01-27 | The Trustees Of The University Of Pennsylvania | Inotropic ADP and ATP analogues and their pharmaceutical compositions |
US5859019A (en) * | 1997-03-07 | 1999-01-12 | Trustees Of The University Of Pennsylvania | Methods for protecting against cardiac ischemia by administering adenosine A2a receptor antagonists |
-
1999
- 1999-02-23 WO PCT/US1999/003881 patent/WO1999043326A1/en active Application Filing
- 1999-02-23 AU AU27818/99A patent/AU2781899A/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
WO1999043326A1 (en) | 1999-09-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU6511999A (en) | Cordless pulse oximeter | |
AU6372900A (en) | Linkage of agents to tissue | |
EP1254952A4 (en) | Cells capable of differentiating into heart muscle cells | |
AU4986899A (en) | Non-invasive glucose monitor | |
AU6257599A (en) | Non-invasive blood component analyzer | |
AU2781899A (en) | Use of a cardiac purinoceptor to effect cellular glucose uptake | |
AU5760900A (en) | Multiple agent diabetes therapy | |
AU2911100A (en) | Skin cosmetic composition | |
AU2557600A (en) | Skin lightening agents | |
AU1041599A (en) | Therapeutic uses of triazolo-pyridazine derivatives | |
AU2001288686A1 (en) | Improved cardiac function through administration of es cells | |
AU5466300A (en) | Rotational-translational double hinge-arm | |
AUPQ877300A0 (en) | Topical treatment of skin | |
AU1784301A (en) | Topical skin composition | |
AU7432398A (en) | Single-use lancets | |
AU1492401A (en) | Cleanser that is gentle to human skin | |
AU1773600A (en) | Topical treatment of skin disease | |
AU7852600A (en) | Iontophoretic delivery to heart tissue | |
AU8038998A (en) | Prophylactic or therapeutic agent for diseases attributable to infection with helicobacters | |
AU4489600A (en) | Absorbent tissues providing skin barrier enhancement | |
GB2352403B (en) | Improvements relating to lancets | |
AU2121200A (en) | Improvements in or relating to sphygmomanometers and other devices | |
AU4491400A (en) | Skin barrier enhancing absorbent tissues | |
AU7801298A (en) | Disposable pant-type diaper having improved fitness to body | |
AU6941598A (en) | Disposable garment having improved fitness to body during use |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MK6 | Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase |